Seller record · Telehealth service
Onyx Weight Loss Clinic
Fails 2 of 8 criteria. S4, compounding disclosure: The GLP-1 and GLP-1 and GIP pages sell weekly injections, daily tablets and sublingual doses without saying whether the medication is compounded or brand-name, and no page carries a statement about FDA approval. 1 more criterion also fails; see the table below.
At a glance
Onyx Weight Loss ClinicTelehealth service
- Price
- GLP-1 medication from $228 a month, GLP-1 and GIP medication from $280
- Sells
- GLP-1 medication (injection or tablet), and 10 more
- FDA letters
- None on file
Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.
A family-founded North Carolina telehealth clinic run by nurse practitioners that sells GLP-1 and dual GLP-1 and GIP medications, phentermine, sermorelin, NAD+, GHK-Cu and PT-141 after a booked consultation. Its product pages do not say whether the GLP-1 medications are compounded, and its contact page names its partner pharmacy.
Operating entity No legal entity name appears in the footer, on the contact page or on the about page, and the footer's privacy policy link leads to a treatment page rather than a policy.
Dispositions
| Code | Criterion | Disposition | Where it appears |
|---|---|---|---|
| S1 | Prescriber requirement | PASS | Onyx Weight Loss Clinic's about page; Onyx Weight Loss Clinic's GLP-1 page |
| S2 | Prescription gating | PASS | Onyx Weight Loss Clinic's GLP-1 page; Onyx Weight Loss Clinic's GLP-1 GIP page |
| S3 | Pharmacy identification | PASS | Onyx Weight Loss Clinic's contact page |
| S4 | Compounding disclosure | FAIL | Onyx Weight Loss Clinic's GLP-1 page; Onyx Weight Loss Clinic's GLP-1 GIP page; Onyx Weight Loss Clinic's weight loss page |
| S5 | Analytical documentation | FAIL | Onyx Weight Loss Clinic's GLP-1 page; Onyx Weight Loss Clinic's peptides page; Onyx Weight Loss Clinic's contact page |
| S6 | Business address | PASS | Onyx Weight Loss Clinic's contact page |
| S7 | Price disclosure | PASS | Onyx Weight Loss Clinic's weight loss page; Onyx Weight Loss Clinic's GLP-1 page; Onyx Weight Loss Clinic's GLP-1 GIP page; Onyx Weight Loss Clinic's sermorelin page; Onyx Weight Loss Clinic's NAD+ page |
| S8 | Enforcement status | PASS | FDA warning-letter index |
Evidence, criterion by criterion
The evidence behind each disposition in the table above, where it appears, and its date.
Products shown on the seller's own pages at the recorded date: GLP-1 medication (injection or tablet), GLP-1 and GIP medication (injection or sublingual), GLP-1 microdosing, phentermine, lipotropic and B12 injections, sermorelin, NAD+, GHK-Cu, PT-141 nasal spray, glutathione nasal spray, bioidentical hormone therapy.
Other sellers of the same products
Who sells sermorelinWho sells NAD+Who sells glutathioneWho sells PT-141Who sells GHK-Cu
Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.